Privigen 10% vial 200ML
Ended Awarded
- Contract number
- SPE2DB25FDRAH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,454
Award facts
- Contract value 100% obligated
- $17,454.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,454.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Privigen 10% vial in 200ml units. This firm fixed-price delivery order, issued on September 8, 2025, with an ultimate completion date of September 29, 2025, represents a direct procurement without set-aside designation. The award falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract (IDC) with DLA valued at $499,999,999 through November 2026, which authorizes the agency to issue delivery orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide.
DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites. The company has consistently secured contracts with DLA covering diverse medical products spanning from specialty oncology treatments to vaccines and immunological products. Privigen, an intravenous immunoglobulin product used for immune deficiency treatment and other immunological conditions, represents the specific therapeutic item covered under this delivery order, enabling DLA to fulfill pharmaceutical requirements across military medical facilities.
Quick answers
Who was awarded contract SPE2DB25FDRAH?
SPE2DB25FDRAH was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FDRAH worth?
The government has obligated $17,454 on SPE2DB25FDRAH.
Is contract SPE2DB25FDRAH an order under another contract?
Yes. SPE2DB25FDRAH is a delivery order under SPE2DB24D9238, an indefinite delivery contract.
Was contract SPE2DB25FDRAH competed?
The extent of competition for SPE2DB25FDRAH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award